Alisoso, Lyka A.

HRN: 29-06-61  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/27/2026
06/02/2026
IV
2.25g
Q8h
T/c Ruptured Appendicitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines